Literature DB >> 356940

The effect of adsorbant and anti-inflammatory drugs on secretion in ligated segments of pig intestine infected with Escherichia coli.

C L Gyles, M Zigler.   

Abstract

Four adsorbant drug preparations, Kaopectate, colloidal Attapulgite, noncolloidal Attapulgite and Pepto-bismol were investigated for their effects on fluid accumulation in ligated segments of pig intestine inoculated with enteropathogenic Escherichia coli. Two anti-inflammatory drugs. aspirin and methylprednisolone, and two antibiotics, lincomycin and polymyxin B, were also tested. All the drugs except the two anti-inflammatory products were given by injection into the lumen of the intestine. Aspirin was given orally and methylprednisolone was given intramuscularly. The antibiotics were tested at levels at which they had no significant antibacterial effect in in vitro tests. The adsorbant drugs colloidal Attapulgite and Pepto-bismol were shown to be effective in reducing fluid accumulation in ligated segments of pig intestine infected with enteropathogenic E. coli. In the case of Peptobismol this effect was associated with an antibacterial effect as well as an antitoxic effect, probably due to its adsorbant properties. It is possible that an aspirin-like effect in the gut due to the active ingredient bismuth subsalicylate may have contributed to the effectiveness of Pepto-bismol. Colloidal Attapulgite was demonstrated to have an antitoxic effect but did not have an antibacterial effect. In high doses, the anti-inflammatory drugs acetylsalicylic acid and methylprednisolone were marginally effective in reduction of fluid accumulation in the same test system. Lincomycin was shown to reduce intestinal fluid secretion, whereas polymyxin B had no effect.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356940      PMCID: PMC1277637     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  34 in total

1.  Adherence of enteropathogenic Escherichia coli to intestinal epithelium in vivo.

Authors:  A Hohmann; M R Wilson
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Escherichia coli enterotoxin: stimulation of adenylate cyclase in broken-cell preparations.

Authors:  F Dorner; P Mayer
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

3.  Inhibition of enterotoxin-induced intestinal secretion by the polypeptide antibiotic, polymyxin.

Authors:  H N Maimon; W E Mitch; J G Banwell; T R Hendrix
Journal:  Johns Hopkins Med J       Date:  1976-03

4.  The effect of attapulgite and charcoal on enterotoxicity of Vibrio cholerae and Escherichia coli enterotoxins in rabbits.

Authors:  M M Drucker; J Goldhar; P L Ogra; E Neter
Journal:  Infection       Date:  1977       Impact factor: 3.553

5.  Inhibition of the steroidogenic effects of cholera and heat-labile Escherichia coli enterotoxins by GM1 ganglioside: evidence for a similar receptor site for the two toxins.

Authors:  S T Donta; J P Viner
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis.

Authors:  M Levner; F P Wiener; B A Rubin
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

7.  Occurrence of K99 antigen on Escherichia coli isolated from pigs and colonization of pig ileum by K99+ enterotoxigenic E. coli from calves and pigs.

Authors:  H W Moon; B Nagy; R E Isaacson; I Orskov
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

8.  Reduction of reactivity of Escherichia coli enterotoxins by intestinal mucosal components.

Authors:  H D Cole; T E Staley; S C Whipp
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Escherichia coli enterotoxin: purification, partial characterization, and immunological observations.

Authors:  F Dorner; H Jaksche; W Stöckl
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

10.  Isolation and properties of heat-labile enterotoxin(s) from enterotoxigenic Escherichia coli.

Authors:  R A Finkelstein; M K LaRue; D W Johnston; M L Vasil; G J Cho; J R Jones
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.